Viewing Study NCT03010358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-02-24 @ 12:55 AM
Study NCT ID: NCT03010358
Status: COMPLETED
Last Update Posted: 2023-08-08
First Post: 2017-01-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
Sponsor: Alexey Danilov, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia View
None B-Cell Prolymphocytic Leukemia View
None Grade 1 Follicular Lymphoma View
None Grade 2 Follicular Lymphoma View
None Grade 3a Follicular Lymphoma View
None Hairy Cell Leukemia View
None Lymphoplasmacytic Lymphoma View
None Mantle Cell Lymphoma View
None Marginal Zone Lymphoma View
None Recurrent Chronic Lymphocytic Leukemia View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Refractory Small Lymphocytic Lymphoma View
None Richter Syndrome View
Keywords: